Longboard pharmaceuticals to present data at upcoming medical meetings

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will present new and encore data at the 35th international epilepsy congress (iec) and the american college of clinical pharmacology (accp) annual meeting. presentation details: iec september 2-6, 2023 – dublin, ireland title: a phase 1 clinical study shows robust lp3.
LBPH Ratings Summary
LBPH Quant Ranking